The Puck Drop Investigates: The Deadly Rise of Pregabalin
Pregabalin, a medication commonly prescribed for epilepsy, pain relief, and anxiety/depression under brand names like Alzain and Lyrica, has been gaining notoriety for all the wrong reasons. The drug, which was originally thought to be a safer alternative to opioids, has now become a cause for concern due to its highly addictive nature.
Reports of widespread dependence on Pregabalin have been surfacing, with a growing number of fatalities linked to its use. The drug’s mortality rate has been on the rise, sparking alarm within the medical community. Despite being classified as a class C drug, a black market has emerged to cater to those addicted to Pregabalin.
It is important to note that Pregabalin is not the same as Gabapentin, another drug used for similar purposes. Users are advised to avoid alcohol, SSRIs, benzodiazepines, and opioids when taking Pregabalin to prevent potentially harmful interactions. Common side effects of the drug include headaches, nausea, fatigue, and mood swings.
To avoid withdrawal symptoms, experts recommend gradually weaning off Pregabalin under medical supervision. Anyone who is concerned about their use or dependence on the drug should seek support from a GP or a drug helpline like Frank.
The Puck Drop urges its readers to stay informed about the risks associated with Pregabalin and to seek help if needed. The growing prevalence of dependence and fatalities linked to this drug serves as a stark warning of its dangers.